Back to top
more

HealthEquity (HQY)

(Real Time Quote from BATS)

$79.75 USD

79.75
74,026

+0.71 (0.90%)

Updated Apr 26, 2024 12:42 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 252)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for HQY

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for HealthEquity, Inc falls in the month of January.

All items in Millions except Per Share data.

1/31/2024 1/31/2023 1/31/2022 1/31/2021 1/31/2020
Assets          
Cash & Equivalents 404 254 225 329 192
Receivables 105 97 87 73 71
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 49 32 39 59 35
Total Current Assets 557 383 351 460 297
Net Property & Equipment 6 13 23 29 33
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 2,484 2,585 2,619 2,094 2,116
Deposits & Other Assets 68 52 50 37 35
Total Assets 3,164 3,089 3,107 2,710 2,565
Liabilities & Shareholders Equity 1/31/2024 1/31/2023 1/31/2022 1/31/2021 1/31/2020
Notes Payable 0 0 0 0 0
Accounts Payable 12 14 28 2 4
Current Portion Long-Term Debt 0 18 9 63 39
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 96 90 105 127 96
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 117 131 153 205 152
Mortgages 0 0 0 0 0
Deferred Taxes/Income 69 83 100 120 130
Convertible Debt 0 0 0 0 0
Long-Term Debt 875 908 922 924 1,182
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 19 13 14 9 3
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,129 1,193 1,255 1,332 1,535
Shareholders Equity 1/31/2024 1/31/2023 1/31/2022 1/31/2021 1/31/2020
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 1,829 1,746 1,677 1,158 819
Retained Earnings 206 150 176 220 212
Other Equity 0 0 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 2,035 1,896 1,853 1,379 1,030
Total Liabilities & Shareholder's Equity 3,164 3,089 3,107 2,710 2,565
Total Common Equity 2,035 1,896 1,853 1,379 1,030
Shares Outstanding 85.80 84.60 83.60 82.10 70.80
Book Value Per Share 23.72 22.41 22.16 16.79 14.55

Fiscal Year End for HealthEquity, Inc falls in the month of January.

All items in Millions except Per Share data.

1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023
Assets          
Cash & Equivalents 404 334 290 226 254
Receivables 105 96 93 98 97
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 49 44 40 34 32
Total Current Assets 557 474 423 358 383
Net Property & Equipment 6 8 9 11 13
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 2,484 2,509 2,530 2,556 2,585
Deposits & Other Assets 68 52 53 53 52
Total Assets 3,164 3,094 3,066 3,035 3,089
Liabilities & Shareholders Equity 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023
Notes Payable 0 0 0 0 0
Accounts Payable 12 13 13 13 14
Current Portion Long-Term Debt 0 0 0 0 18
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 96 73 81 66 90
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 117 96 103 90 131
Mortgages 0 0 0 0 0
Deferred Taxes/Income 69 67 75 82 83
Convertible Debt 0 0 0 0 0
Long-Term Debt 875 874 874 873 908
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 19 13 13 13
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,129 1,106 1,117 1,116 1,193
Shareholders Equity 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 1,829 1,809 1,785 1,765 1,746
Retained Earnings 206 179 165 154 150
Other Equity 0 0 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 2,035 1,988 1,950 1,919 1,896
Total Liabilities & Shareholder's Equity 3,164 3,094 3,066 3,035 3,089
Total Common Equity 2,035 1,988 1,950 1,919 1,896
Shares Outstanding 85.80 85.80 85.40 85.40 84.60
Book Value Per Share 23.72 23.17 22.83 22.47 22.41